Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | 0.00% | +27.27% | -2.10% |
Financials (USD)
Sales 2024 * | 62.7M | Sales 2025 * | 71M | Capitalization | 19.88M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -9M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-0.97
x | P/E ratio 2025 * |
-2.02
x | Employees | 380 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.35% |
Latest transcript on Trinity Biotech plc
1 week | +27.27% | ||
Current month | +27.27% | ||
1 month | +26.51% | ||
3 months | -5.83% | ||
6 months | -23.64% | ||
Current year | -2.10% |
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.1 | 0.00% | 44,739 |
24-06-06 | 2.1 | +5.00% | 47,961 |
24-06-05 | 2 | +10.78% | 140,112 |
24-06-04 | 1.805 | +4.35% | 41,935 |
24-06-03 | 1.73 | +4.85% | 25,755 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.10% | 19.88M | |
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
+15.67% | 2B |
- Stock Market
- Equities
- TRIB Stock